Home / Terbinafine / Czechia
CZ ATC D01AE15 · updated 2 Nov 2026
Terbinafine shortage in Czechia
Is there a Terbinafine shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Terbinafine products are reported short in Czechia, the first since 1 Aug 2026. The company estimate for the return is 20 Dec 2026 (latest 31 Jan 2027). Main reason: manufacturing problem.
Also short in Spain, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TERBISTAD 10MG/G 10MG/G CRM 1X15G | STADA Arzneimittel AG, Bad Vilbel | 1 Aug 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | LAMISIL 10MG/G 10MG/G CRM 1X15G II+MEMBRÁNA | Karo Healthcare AB, Stockholm | 13 Sep 2026 | 20 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.